These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36680154)

  • 1. Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice.
    Amruta N; Ismael S; Leist SR; Gressett TE; Srivastava A; Dinnon KH; Engler-Chiurazzi EB; Maness NJ; Qin X; Kolls JK; Baric RS; Bix G
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
    Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
    mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Adapted SARS-CoV-2 Model Induces "Long-COVID" Neuropathology in BALB/c Mice.
    Gressett TE; Leist SR; Ismael S; Talkington G; Dinnon KH; Baric RS; Bix G
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice.
    Stone S; Rothan HA; Natekar JP; Kumari P; Sharma S; Pathak H; Arora K; Auroni TT; Kumar M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal positron emission tomography and postmortem analysis reveals widespread neuroinflammation in SARS-CoV-2 infected rhesus macaques.
    Nieuwland JM; Nutma E; Philippens IHCHM; Böszörményi KP; Remarque EJ; Bakker J; Meijer L; Woerdman N; Fagrouch ZC; Verstrepen BE; Langermans JAM; Verschoor EJ; Windhorst AD; Bontrop RE; de Vries HE; Stammes MA; Middeldorp J
    J Neuroinflammation; 2023 Jul; 20(1):179. PubMed ID: 37516868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I links with severe pathogenicity in C57BL/6N mice infected with SARS-CoV-2/BMA8.
    Qin T; Shen B; Li E; Jin S; Luo R; Zhang Y; Qi J; Deng X; Shi Z; Wang T; Zhou Y; Gao Y
    Virol J; 2023 Apr; 20(1):75. PubMed ID: 37081549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
    Leist SR; Dinnon KH; Schäfer A; Tse LV; Okuda K; Hou YJ; West A; Edwards CE; Sanders W; Fritch EJ; Gully KL; Scobey T; Brown AJ; Sheahan TP; Moorman NJ; Boucher RC; Gralinski LE; Montgomery SA; Baric RS
    Cell; 2020 Nov; 183(4):1070-1085.e12. PubMed ID: 33031744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    Muruato A; Vu MN; Johnson BA; Davis-Gardner ME; Vanderheiden A; Lokugamage K; Schindewolf C; Crocquet-Valdes PA; Langsjoen RM; Plante JA; Plante KS; Weaver SC; Debbink K; Routh AL; Walker D; Suthar MS; Shi PY; Xie X; Menachery VD
    PLoS Biol; 2021 Nov; 19(11):e3001284. PubMed ID: 34735434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    Abdelnabi R; Foo CS; Kaptein SJF; Boudewijns R; Vangeel L; De Jonghe S; Jochmans D; Weynand B; Neyts J
    J Virol; 2022 Aug; 96(16):e0075822. PubMed ID: 35924921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
    Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
    Front Immunol; 2022; 13():893792. PubMed ID: 35812400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
    Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
    Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Dinnon KH; Leist SR; Baric RS; Barouch DH
    bioRxiv; 2021 Jun; ():. PubMed ID: 34159335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.